Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1926-30. Epub 2003 Feb 5.

Variation in gene expression patterns in follicular lymphoma and the response to rituximab.

Author information

1
Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.

Abstract

Analysis of the patterns of gene expression in follicular lymphomas from 24 patients suggested that two groups of tumors might be distinguished. All patients, whose biopsies were obtained before any treatment, were treated with rituximab, a monoclonal antibody directed against the B cell antigen, CD20. Gene expression patterns in the tumors that subsequently failed to respond to rituximab appeared more similar to those of normal lymphoid tissues than to gene expression patterns of tumors from rituximab responders. These findings suggest the possibility that the response of follicular lymphoma to rituximab treatment may be predicted from the gene expression pattern of tumors.

PMID:
12571354
PMCID:
PMC149935
DOI:
10.1073/pnas.0437875100
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center